In the DeSci track, BIO's leading position has basically been established, while the ownership of 'Dragon Two' has become the focus of market attention. VITA is currently a prominent potential candidate.

From a trend perspective, VITA possesses certain competitiveness, with its core advantage being its background — as a biotechnology-related project jointly invested by Pfizer and Binance, it is an important part of the BIO ecosystem, providing strong backing for its subsequent development.

However, it should be noted that $VITA is currently only listed on the Binance Alpha platform, which presents two key risk points:

• Liquidity performance is average, which may affect trading convenience and price stability;

• The overall uncertainty of the project is relatively high, and development expectations are not yet fully clear.

However, market规律 often shows that high uncertainty often conceals opportunities for excess returns, so the investment value of $VITA must be weighed between risk and potential return. $BTC $ETH #亚洲家族办公室加密资产配置 #美国初请失业金人数 #美联储7月会议纪要